Skip to main
DCGO

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

DocGo is poised for strong growth in the coming years, with positive y/y volume growth across several core lines of business and successful expansion of its national payer relationship. Additionally, the company's focus on cost management and integration of its proprietary logistics platform and lower-cost staffing model contribute to strong margins and positioning in a large secular market for in-home clinical services. With a diverse portfolio and potential for mid-teens-plus earnings growth after 2026, DocGo has a promising outlook for continued success.

Bears say

DocGo is a healthcare company with two primary segments, Mobile Health Services and Transportation Services. Despite recent efforts to grow revenue and reduce costs, the company is facing challenges in ramping up business and achieving profitability. Additionally, their reliance on migrant-related revenue may have a negative impact on margins. Uncertainties around their ability to rightsize expenses and expand into new markets may further hinder their growth potential, leading to a discontinuation of coverage by analysts and a "show me" stance from investors.

DocGo (DCGO) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Buy based on their latest research and market trends.

According to 4 analysts, DocGo (DCGO) has a Buy consensus rating as of Jun 27, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.